A Longitudinal Study of Movement and Participation in Patients With Cerebral Palsy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01903603|
Recruitment Status : Completed
First Posted : July 19, 2013
Last Update Posted : September 11, 2017
|Condition or disease|
Cerebral palsy (CP) may lead to various motor deficits, which further influence the activities and participation. It would be ideal to characterize neural network and motor control model in patients with CP that underlies their clinical behavior by identifying altered neural network and motor control associated with behavioral improvement. The aim of this study is to investigate the brain image and motor control in patients with CP evaluated by multimodal imaging studies utilizing multi-modal techniques and kinematic analysis.
This study includes a prospective longitudinal study of patients with CP over one-year. This study will be executed in 3 phases within 3 years: 1st phase (1st years): to establish the multimodal brain images and motor control, and clinical outcomes protocol with a prospective one-year follow-up study in healthy subjects; 2nd phase (2nd years): to establish the brain images and motor control, and clinical outcomes with a prospective one-year follow-up study in older patients with CP; and 3rd phase (3rd years): to establish the brain images and motor control, and clinical outcomes with a prospective one-year follow-up study in younger patients with CP. In a prospective longitudinal study, each participant received 3-times measurements: at the beginning, 6 months later, and one year after the first data collection point
|Study Type :||Observational|
|Actual Enrollment :||80 participants|
|Official Title:||A Longitudinal Study of Movement and Participation in Patients With Cerebral Palsy: a Combined Brain Imaging and Kinematic Analysis|
|Study Start Date :||August 2012|
|Actual Primary Completion Date :||June 2017|
|Actual Study Completion Date :||June 2017|
Inclusion criteria for healthy children were as follows: ages of 4-20 y/o ; good cognition and cooperation; and healthy children.
Inclusion criteria for subjects with brain damage by CP were as follows: a diagnosis of CP and aged 4-20 years old.
- Change from baseline of functional magnetic resonance imaging (fMRI) analysis in 6 months and 12 months [ Time Frame: baseline, 6 months, 12 months ]fc(functional connectivity)MRI at resting, active-task fMRI. diffusion tensor imaging (DTI)
- Change from baseline of kinematic analysis in 6 months and 12 months [ Time Frame: baseline, 6 months, 12 months ]Kinematic analysis for upper limb and gait analysis
- Change from baseline of movement and participation for Healthy children and CP in 6 months and 12 months [ Time Frame: 6 months and 12 months ]Healthy children and CP: Bruininks- Oseretsky Test of Motor Proficiency II (BOT-2), Wolf Motor Function Test (WMFT), Block and Box test (BBT), Time up and go, Berg Balance Scale (BBS), Functional Independence Measure for Children (WeeFIM), Children Assessment of Participation and Enjoyment (CAPE), and School Function Assessment (SFA).
- Change from baseline of movement and participation for CP in 6 months and 12 months [ Time Frame: baseline, 6 months, 12 months ]Measures for CP also include Gross motor function measure (GMFM), Quality of upper extremity test (QUEST), Pediatric Motor Activity Log (PMAL), Caregiver Functional Use Survey (CFUS), etc.
- Change from baseline of severity for CP patients in 6 months and 12 months [ Time Frame: baseline, 6 months, 12 months ]CP patients: Gross Motor Functional Classification System (GMFCS), Manual Ability Classification System (MACS), Modified Ashworth Scale (MAS), strength and endurance, selective control, etc
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01903603
|Chang Gung Memorial Hospital|
|Taoyuan, Taiwan, 333|
|Principal Investigator:||Chia-Ling Chen, PhD||Department of Physical Medicine & Rehabilitation, Chang Gung Memorial Hospital|